Carmela Viscomi
Overview
Explore the profile of Carmela Viscomi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
44
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Conti B, Porcu C, Viscomi C, Minutolo A, Costantini S, Corazzari M, et al.
Oncotarget
. 2016 Sep;
7(51):84575-84586.
PMID: 27661118
HCV life cycle is strictly correlated with the hepatocyte lipid metabolism; moreover, the progression of HCV chronic hepatitis is accelerated by the presence of liver steatosis. Among the steatogenic genes...
2.
Arciello M, Longo A, Viscomi C, Capo C, Angeloni A, Rossi L, et al.
Biometals
. 2015 Oct;
28(6):1017-29.
PMID: 26438057
Nonalcoholic fatty liver disease (NAFLD) is a pathology that includes a wide variety of clinical conditions ranging from simple steatosis to end-stage liver diseases. Despite the huge amount of researches,...
3.
Maggio R, Viscomi C, Andreozzi P, DEttorre G, Viscogliosi G, Barbaro B, et al.
PLoS One
. 2014 Dec;
9(12):e112346.
PMID: 25532016
Unlabelled: Hepatitis C virus (HCV) infection is associated with hepatic and extrahepatic manifestations, including immunological disorders. Chronic Hepatitis C (CHC) is often characterized by cholesterol and lipid metabolism alterations, leading...
4.
Minutolo A, Conti B, Grelli S, Viscomi C, Labbadia G, Balsano C
PLoS One
. 2014 Mar;
9(3):e92343.
PMID: 24658135
Hepatitis C virus infection leads to a wide spectrum of liver diseases ranging from mild chronic hepatitis to end-stage cirrhosis and hepatocellular carcinoma. An intriguing aspect of the HCV infection...
5.
Gori M, Barbaro B, Arciello M, Maggio R, Viscomi C, Longo A, et al.
J Cell Physiol
. 2014 Jan;
229(9):1182-92.
PMID: 24395441
Nonalcoholic fatty liver disease (NAFLD) ranges from simple steatosis to steatohepatitis, which may progress to fibrosis, and cirrhosis, leading eventually to hepatocarcinoma development. Recently, cases of hepatocarcinoma have been diagnosed...